Administrative Review Board - April 2021 | U.S. Department of Labor
U.S. Department of Labor· 5 days agoThe ARB dismissed the SOX complaint because Complainant filed a notice of the filing of an original action with the United States District Court for the Eastern District of New York. The ARB ...
Thorny Issues Raised by Third-Party Discovery in Arbitration | New York Law Journal
Law.com· 4 days agoIn an arbitration, third-party discovery—i.e., seeking documents or testimony from non-parties—can...
The Reorientations of Edward Said
The New Yorker· 4 days agoMultiple and clashing selves were Said’s inheritance from the moment of his birth, in 1935, in West Jerusalem, where a midwife chanted over him in both...
'Long and Steady Erosion of the Jury Trial' | Ted Olson Fights FISA Secrecy | Stanford's Jeffrey...
Law.com· 3 days agoGibson, Dunn & Crutcher’s Theodore Olson takes the lead on a new petition challenging secrecy in the...
Ronald White - The Tribune
The Ironton Tribune· 7 days agoRonald White Oct. 12, 1943–April 14, 2021 Ronald Lee White, 77, of Ironton, passed away Wednesday, April 14, 2021, at his residence. The Marion native...
U.S. to allocate $1.7B to track variants' spread
Arkansas Democrat-Gazette· 6 days agoThe U.S. is setting up a $1.7 billion national network to identify and track the spread of worrisome coronavirus mutations that could trigger another...
New Bill Would Ban Clearview and Warrantless Location Data Purchases
Vice· 2 days agoA sweeping proposed piece of legislation with support from both Democrats and Republicans will ban...
These teens escaped life without parole. But they will still die in MS prisons.
The Biloxi Sun Herald· 20 hours agoThese teens escaped life without parole. Of those “virtual lifers,” 22 were juveniles like him when...
OFFICER PROMOTIONS FOR MAY 2021 AND PROJECTED OFFICER PROMOTIONS FOR JUNE 2021
U.S. Marine Corps· 2 days agoR 211220Z APR 21MARADMIN 219/21MSGID/GENADMIN/CMC WASHINGTON DC MRA MM//SUBJ/OFFICER PROMOTIONS FOR MAY 2021 AND PROJECTED OFFICER PROMOTIONS FOR JUNE 2021//REF/A/MSGID: DOC/CONGRESS//REF/B/MSGID:
TG Therapeutics Announces Positive Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in...
Morningstar· 7 days agoUblituximab demonstrated superiority versus teriflunomide in reducing annualized relapse rates and MRI brain lesions Ublituximab was generally well tolerated, with no unexpected safety signals BLA submission targeted in Q3 2021 Webcast to be held
Yahoo Web Search
Trending Now
